Skip to main content

Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy.

Publication ,  Conference
Downie, BJ; Erba, HP; Stone, RM; Rizzieri, DA; Foran, JM
Published in: Blood
November 20, 2009

Abstract 2076Poster Board II-53

Duke Scholars

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 20, 2009

Volume

114

Issue

22

Start / End Page

2076 / 2076

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Downie, B. J., Erba, H. P., Stone, R. M., Rizzieri, D. A., & Foran, J. M. (2009). Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy. In Blood (Vol. 114, pp. 2076–2076). American Society of Hematology. https://doi.org/10.1182/blood.v114.22.2076.2076
Downie, Ben J., Harry P. Erba, Richard M. Stone, David A. Rizzieri, and James M. Foran. “Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy.” In Blood, 114:2076–2076. American Society of Hematology, 2009. https://doi.org/10.1182/blood.v114.22.2076.2076.
Downie, Ben J., et al. “Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy.Blood, vol. 114, no. 22, American Society of Hematology, 2009, pp. 2076–2076. Crossref, doi:10.1182/blood.v114.22.2076.2076.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 20, 2009

Volume

114

Issue

22

Start / End Page

2076 / 2076

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology